AstraZeneca - 25 Year Stock Price History | AZN

Historical daily share price chart and data for AstraZeneca since 1993 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for AstraZeneca as of December 17, 2018 is 38.35.
AstraZeneca Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 36.4781 34.0322 41.4900 32.3297 38.3500 14.90%
2017 30.1933 25.4163 33.5014 24.5083 33.3781 33.20%
2016 27.2367 29.3037 31.4425 23.6736 25.0586 -15.87%
2015 29.1757 29.6387 31.7491 26.5664 29.7863 0.53%
2014 29.3472 23.6552 33.6965 23.6309 29.6302 23.57%
2013 20.2017 18.3787 24.0308 17.7237 23.9783 33.14%
2012 17.1487 17.1028 18.6302 14.9654 18.0092 8.55%
2011 16.8137 15.6928 18.4252 14.6765 16.5903 6.11%
2010 15.8885 15.2528 18.1097 13.6620 15.6353 3.53%
2009 13.2510 12.4023 15.1209 9.6076 15.1016 20.46%
2008 12.7608 12.3897 15.0881 10.4193 12.5367 0.26%
2007 15.0187 15.2539 17.0660 12.5036 12.5036 -17.51%
2006 15.6995 13.8486 18.7864 12.6691 15.1576 13.28%
2005 11.8731 9.7314 13.6283 9.3284 13.3806 36.86%
2004 12.0083 12.9330 13.5709 9.6400 9.7771 -23.43%
2003 10.6222 9.0120 13.0571 7.7589 12.7694 40.85%
2002 10.4785 11.6203 13.3233 7.5315 9.0662 -23.27%
2001 11.8562 12.6887 12.8920 10.6487 11.8156 -8.00%
2000 10.7394 9.8491 13.0303 7.5431 12.8433 28.46%
1999 9.9723 10.7742 11.4655 8.4235 9.9976 -5.53%
1998 9.5550 8.4301 11.4824 7.6049 10.5832 26.70%
1997 7.1799 6.2200 8.7124 6.1253 8.3527 31.28%
1996 5.1356 4.3816 6.4760 4.2152 6.3624 47.39%
1995 3.6255 2.9381 4.5850 2.8844 4.3166 46.49%
1994 2.5428 2.5530 3.0191 2.1550 2.9467 14.65%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $97.137B $22.465B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.470B 16.24
Pfizer (PFE) United States $256.628B 14.47
Merck (MRK) United States $202.834B 17.58
Novartis AG (NVS) Switzerland $198.106B 16.98
AbbVie (ABBV) United States $127.753B 11.34
Eli Lilly (LLY) United States $114.788B 20.18
Novo Nordisk (NVO) Denmark $112.867B 18.33
Sanofi (SNY) France $109.302B 13.53
GlaxoSmithKline (GSK) United Kingdom $91.931B 12.36
Bristol-Myers Squibb (BMY) United States $83.112B 13.69